Among those meeting the criteria for hypertension at presentation, 120 (12.6%) were on angiotensin converting enzyme inhibitors (ACE-I), 100 (10.5%) on angiotensin receptor blockers (ARB), 56 (5.9%) on diuretics, 49 (5.1%) on calcium antagonists, 31 (3.2%) on beta-blockers and 5 (0.5%) on alpha-blockers. The gene discussed is ACE; the disease is hypertensive disorder.